WellTheory
Atherton
About WellTheory
WellTheory provides a virtual care platform focused on autoimmune and inflammatory health. It delivers personalized nutrition, lifestyle, and root-cause assessments, then matches each member with a multidisciplinary Care Team including dietitians, health coaches, and support coordinators. The company supports users through live coaching sessions, unlimited messaging, educational content, community connection, and advanced testing as needed. For employer and payer customers, it offers an enterprise solution that integrates with existing benefit systems, handles implementation, communications, and reporting, and aims to reduce autoimmune-related medical spend.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2025)
- Website: welltheory.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Medical, Personal Health, Wellness
Social Profiles
Canonical: https://fsome.com/organization/welltheory-37856 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.